作者: Joseph Luber , Frank Bunick
DOI:
关键词:
摘要: The present invention features an orally disintegrating dosage form including from about 5% to 40%, by weight, of at least one hydrated salt and a pharmaceutically active agent, wherein the has dehydration temperature 20 120 °C.